James Felker
Advanced in Diffuse Midline Glioma H3 K27M-Mutant
Advanced in Diffuse Midline Glioma H3 K27M-Mutant
4401 Penn Avenue, 
Pittsburgh, PA 

Overview

James Felker, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is assistant professor of medicine at the University of Pittsburgh School of Medicine. Dr. Felker received his medical degree from New York Medical College and completed his residency at Northwestern University/Ann & Robert H. Lurie Children’s Hospital of Chicago followed by a fellowship in pediatric hematology/oncology and neuro-oncology at Emory University/Children’s Healthcare of Atlanta, Ga. Dr. Felker’s clinical interests include pediatric brain and spinal tumors and clinical trial development. He has published numerous articles in peer-reviewed journals and is a member of the American Society of Pediatric Hematology/Oncology, American Society of Clinical Oncology, Society for Neuro-Oncology, Children’s Oncology Group, and the Pediatric Brain Tumor Consortium. His wife is a pediatric cardiologist at UPMC Children’s and has an interest in long term cardiac outcomes for oncology patients. Together they have two girls and a beagle mutt. Dr Felker enjoys running along the rivers in Pittsburgh while trying to avoid the hills. View the full list of Dr. Felker's publications on PubMed. View Dr. Felker's profile at the University of Pittsburgh School of Medicine – Department of Pediatrics. LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling.

Dr. Felker is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Brain Stem Cancer, Glioma, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 2 clinical trials in the study of Diffuse Midline Glioma H3 K27M-Mutant.

Graduate Institution
New York Medical College
Residency
McGaw Medical Center of Northwestern University
Specialties
Pediatric Hematology Oncology
Licenses
Pediatrics in GA
Board Certifications
American Board Of Pediatrics
American Board Of Pediatrics
Fellowships
Emory University School of Medicine
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 8 Less Insurance Carriers -

Locations

Pediatric Hematology Oncology in Lawrenceville
4401 Penn Avenue, Pittsburgh, PA 15224

Additional Areas of Focus

Dr. Felker has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
View 7 Less Clinical Trials
Similar Doctors
Scott H. Maurer
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatric Hematology Oncology
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatric Hematology Oncology

Pediatric Palliative Medicine And Supportive Care

4401 Penn Avenue, 
Pittsburgh, PA 
 (0.1 miles away)
Languages Spoken:
English
Accepting New Patients

Scott Maurer, MD, is a pediatric palliative care physician and a pediatric oncologist. Dr. Maurer is certified in pediatrics, pediatric hematology/oncology, and hospice and palliative medicine by the American Board of Pediatrics. He is the chief of the division of palliative medicine and supportive care at UPMC Children’s Hospital of Pittsburgh and is an associate professor of pediatrics at the University of Pittsburgh School of Medicine. Dr. Maurer is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Infantile Neutropenia, Rosai-Dorfman Disease, Leukemia, and Pediatric Low-Grade Glioma (pLGG).

Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatric Hematology Oncology
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatric Hematology Oncology

UPMC Children's Hospital Of Pittsburgh, Pediatric Hematology/Oncology

4401 Penn Avenue, Floor 3, 
Pittsburgh, PA 
 (0.1 miles away)
Languages Spoken:
English, Cantonese, Mandarin
Accepting New Patients

Benison Lau, MD, specializes in pediatric hematology oncology and is board-certified in pediatrics by the American Board of Pediatrics and internal medicine and American Board of Internal Medicine. He is affiliated with UPMC Children's Hospital of Pittsburgh. Dr. Lau completed his residency at the University of Massachusetts Medical School and medical degree at the University of Illinois College of Medicine at Peoria. Dr. Lau is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Glioma, Thalassemia, Diffuse Midline Glioma H3 K27M-Mutant, Immune Thrombocytopenic Purpura (ITP), and Deep Brain Stimulation.

Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatrics | Pediatric Hematology Oncology | Hematology
Experienced in Diffuse Midline Glioma H3 K27M-Mutant
Pediatrics | Pediatric Hematology Oncology | Hematology
4262 Old William Penn Hwy Ste 208, 
Murrysville, PA 
 (14.9 miles away)
Languages Spoken:
English

Nathan Millard is a Pediatrics specialist and a Pediatric Hematologist Oncology provider in Murrysville, Pennsylvania. Dr. Millard is rated as an Experienced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Medulloblastoma, Gliomatosis Cerebri, and Neuroblastoma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Felker's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile